Health Invesco Increases Stake in Blueprint Medicines with New Share Acquisition Investment firm Invesco Ltd. has boosted its stake in Blueprint Medicines Corporation (NASDAQ: BPMC) by 2.5% during the first quarter of 2023. According to... Editorial11 hours ago